Stoke Therapeutics Inc (STOK) — Cash Flow Reinvestment Rate
Stoke Therapeutics Inc (STOK) has a Cash Flow Reinvestment Rate of 0.10x as of March 2025, reinvesting $13.78 Million (capex $152.00K plus investments $13.63 Million) from operating cash flow of $131.83 Million. See free cash flow generation of Stoke Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Stoke Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Stoke Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Stoke Therapeutics Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Stoke Therapeutics Inc (2025–2025)
Year-by-year capital reinvestment analysis for Stoke Therapeutics Inc. See STOK free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.10x | $186.81 Million | $45.59 Million | $670.00K | — |